Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients

Breast Cancer Research and Treatment

Volumn 136, Issue 3, 2012, Pages 931-933

  Kwong, Ava ^a,b,c,d   Ng, Enders K O ^a,b   Law, Fian B F ^b   Wong, H N ^a   Wa, Anna ^a   Wong, Chris L P ^b,c   Kurian, Allison W ^d   West, Dee W ^d   Ford, James M ^d   Ma, Edmond S K ^b,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^c Hong Kong Hereditary Breast Cancer Family Registry   (Hong Kong)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; COMPLEMENTARY DNA; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

BREAST CANCER; CANCER PATIENT; CHINESE; CHROMOSOME BREAKAGE; DNA SEQUENCE; DOWN REGULATION; ETHNICITY; EXON; FAMILY HISTORY; GENE DELETION; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENE SEQUENCE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; LETTER; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TUMOR SUPPRESSOR GENE; ADOLESCENT; ADULT; AGED; ASIAN; BREAST TUMOR; FEMALE; GENETICS; MIDDLE AGED; MUTATION; OVARY TUMOR; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENE REARRANGEMENT; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; YOUNG ADULT;

EID: 84878763949     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2292-1     Document Type: Letter

References (20)

1. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676-689
2. Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, et al. (1996) Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 6:1029-1049
3. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, et al. (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379-1388
4. Bunyan DJ, Eccles DM, Sillibourne J, Wilkins E, Thomas NS, et al. (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155-1159
5. Machado PM, Brandao RD, Cavaco BM, Eugenio J, Bento S, et al. (2007) Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J Clin Oncol 25:2027-2034
6. Hendrickson BC, Judkins T, Ward BD, Eliason K, Deffenbaugh AE, et al. (2005) Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families. Genes Chromosomes Cancer 43:309-313
7. Mazoyer S (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25:415-422
8. Kwong A, Wong LP, Wong HN, Law FB, Ng EK, et al. (2009) A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat 117:683-686
9. Sellner LN, Taylor GR (2004) MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 23:413-419
10. Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, et al. (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63:1449-1453
11. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, et al. (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57
12. Moisan AM, Fortin J, Dumont M, Samson C, Bessette P, et al. (2006) No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families. Genet Test 10:104-115
13. Edwards E, Yearwood C, Sillibourne J, Baralle D, Eccles D (2009) Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer. Fam Cancer 8:479-482
14. Robson M, Scheuer L, Nafa K, Ellis N, Offit K (2002) Unique de novo mutation of BRCA2 in a woman with early onset breast cancer. J Med Genet 39:126-128
15. Tesoriero A, Andersen C, Southey M, Somers G, McKay M, et al. (1999) De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. Am J Hum Genet 65:567-569
16. van der Luijt RB, van Zon PH, Jansen RP, van der Sijs-Bos CJ, Warlam-Rodenhuis CC, et al. (2001) De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer. J Med Genet 38:102-105
17. Hansen TV, Bisgaard ML, Jonson L, Albrechtsen A, Filtenborg-Barnkob B, et al. (2008) Novel de novo BRCA2 mutation in a patient with a family history of breast cancer. BMC Med Genet 9:58
18. Kwong A, Ng EK, Tang EY, Wong CL, Law FB, et al. (2011) A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer. Fam Cancer 10:233-237
19. Kwong A, Ng EK, Law FB, Wong LP, To MY, et al. (2010) High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients. Breast Cancer Res Treat
20. Kwong A, Ng EK, Wong CL, Law FB, Au T, et al. (2012) Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using Gene sequencing and high resolution DNA melting analysis. Plos One 7:e43994